The Deal
With similar business models and reputations for outstanding customer service, ASID BONZ and Medline have an excellent strategic fit. As a result of this transaction, Medline will take the ASID BONZ brand outside of Germany, offering its products to its broad European customer base. Within Germany, the ASID BONZ sales force will have access to Medline products to strengthen their partnership with customers.
The Target
ASID BONZ is a leading supplier to hospitals in Germany, offering high-quality surgery, anaesthesia, ward-supply and urology products. Asid Bonz was founded in 1811 and is known worldwide for developing the first anaesthetic ether. In 2021, Asid Bonz recorded over €30m in revenues and served over 1.100 hospitals in Germany.
About Duke Street Private Equity
Duke Street is a UK based PE house focused on investing in mature, mid-market Western European businesses. Their investment strategy concentrates on four sectors: Consumer, Healthcare, Industrials & Engineering and Services. Duke Street typically invest in companies with an enterprise value of between £50m – £350m.
About Medline
Medline is a leading global healthcare company that manufactures and distributes quality medical and surgical supplies with superior value. Medline employs 27,000 people worldwide and has a strong presence in North America and Europe.
Medline Europe was established in 2011. Since then, the company has expanded rapidly throughout the continent, serving customers in 27 European countries and with offices, manufacturing, and distribution centres across the continent.
